All Stories

  1. Investigation of in vitro anticancer and antioxidant activities of various extracts of Bayramiç Beyazı nectarine, and molecular docking, molecular dynamics simulation, and protein-protein interaction network
  2. Boron Containing Curcumin-Like Compound as an Acetylcholinesterase Inhibitor and Anticancer Agent: Synthesis, Biological Evaluation, and Computational Insights
  3. New and potential boron-containing compounds for treatment of Alzheimer's disease and cancers
  4. Synthesis, in silico and bio-evaluation studies of new isothiocyanate derivatives with respect to COX inhibition and H2S release profiles
  5. Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies
  6. A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
  7. Nitro Compounds Inhibit Breast Cancer Cell Proliferation, Migration, and Colony Formation: Molecular Docking, Molecular Dynamics Simulations and Pharmacological Properties
  8. Synthesis of new imine-/amine-bearing imidazo[1,2-a]pyrimidine derivatives and screening of their cytotoxic activity
  9. Major Bioactive Prenylated Flavonoids from Humulus lupulus L., Their Applications in Human Diseases and Structure-Activity Relationships (SAR) – A Review
  10. Humidity effect on real-time response of tetranitro-oxacalix[4]arene-based surface plasmon resonance (SPR) acetone sensor at room temperature
  11. Identifying highly effective coumarin-based novel cholinesterase inhibitors by in silico and in vitro studies
  12. Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy
  13. Novel inhibitors of eukaryotic elongation factor 2 kinase: In silico, synthesis and in vitro studies
  14. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects
  15. Prodrugs for Nitroreductase Based Cancer Therapy‐5: Development of Trinitroaniline Prodrugs/Ssap‐NtrB Combinations for Liver Cancer Using Intracellular and Extracellular Conditions
  16. Correction to “Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo”
  17. Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo
  18. Prodrugs for nitroreductase based cancer therapy-4: Towards prostate cancer targeting: Synthesis of N-heterocyclic nitro prodrugs, Ssap-NtrB enzymatic activation and anticancer evaluation
  19. Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growthin vivo
  20. A room temperature acetone sensor based on synthesized tetranitro-oxacalix[4]arenes: Thin film fabrication and sensing properties
  21. Synthesis and biological evaluation of 2,4,6-trinitroaniline derivatives as potent antitumor agents
  22. Nitroreductases in Prodrug Therapies
  23. Delivery of Small Molecule EF2 Kinase Inhibitor for Breast and Pancreatic Cancer Cells Using Hyaluronic Acid Based Nanogels
  24. Design, Synthesis, and Molecular Modeling Studies of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors
  25. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer
  26. In vitro and in silico studies of nitrobenzamide derivatives as potential anti-neuroinflammatory agents
  27. Synthesis of SMZ derivatives and investigation of effects on germination, root,and plant growth ofArabidopsis thalianaL.
  28. Surface‐modified carbon black derived from used car tires as alternative, reusable, and regenerable catalysts for H 2 release studies from sodium borohydride methanolysis
  29. Abstract 4787: New and potent small molecule as EF2K inhibitor: A novel EF2K inhibitor
  30. PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY- 2: Novel amide/Ntr combinations targeting PC3 cancer cells
  31. Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery
  32. Prodrugs for Nitroreductase Based Cancer Therapy- 1: Metabolite Profile, Cell Cytotoxicity and Molecular Modeling Interactions of Nitro Benzamides with Ssap-NtrB
  33. Electrochemical behavior and voltammetric determination of some nitro-substituted benzamide compounds
  34. Biological evaluation and molecular docking studies of nitro benzamide derivatives with respect to in vitro anti-inflammatory activity
  35. Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen
  36. Antiproliferative activity ofHumulus lupulusextracts on human hepatoma (Hep3B), colon (HT-29) cancer cells and proteases, tyrosinase,β-lactamase enzyme inhibition studies
  37. Comparative Study of Antioxidant Properties and Total Phenolic Content of the Extracts of Humulus lupulus L. and Quantification of Bioactive Components by LC–MS/MS and GC–MS
  38. Two New Phenylpropanoid Glycosides from the Leaves and Flowers ofErica arborea
  39. Antioxidant phenolic compounds from the leaves ofErica Arborea(Ericaceae)
  40. Tricetin 4′-O-α-L-rhamnopyranoside: A new flavonoid from the aerial parts of Erica arborea
  41. Antioxidant activity of Erica arborea
  42. A new flavone from antioxidant extracts of Pistacia terebinthus
  43. X-ray analysis of sideroxol from Sideritis leptoclada
  44. Highly stereoselective and general synthesis of (z)-3-methyl-2-alken-1-ols via palladium-catalyzed cross coupling of (z)-3-iodo-2-buten-1-ol with organozincs and other organometals
  45. Selective synthesis of benzene derivatives via palladium-catalyzed cascade carbometallation of alkynes
  46. Cyclic cascade carbopalladation reactions as a route to benzene and fulvene derivatives
  47. Electrophilic amination of carbanions
  48. Effect of Copper (I) Iodide and Magnesium Chloride on Amination of Aryl Grignards with Ketoximes